Cikakken Bayani
Nau'in samfurori: Saliva
Lokacin gwaji: Minti 15
Hankali: 98.10%
Musamman:> 99.33%
Marufi & Bayarwa
| Cikakken bayanin marufi: daidaitaccen fakitin fitarwa Bayanin isarwa: a cikin kwanakin aiki 7-10 bayan an karɓi biyan kuɗi |
Ƙayyadaddun bayanai
Lepu Medical COVID-19 Kit ɗin Gwajin Antigen AMDNA12
The Lepu Medical COVID-19 Antigen Saliva Kit Kit AMDNA12 ana amfani da shi don gano ingantacciyar ƙwayar cuta ta coronavirus (COVID-19) antigen a cikin samfurin salwa, kawai don amfani da bincike na in vitro.
Ana amfani da Kit ɗin gwajin Antigen na Lepu COVID-19 don gano ingantattun antigen novel coronavirus (COVID-19) a cikin samfurin salwa, kawai don amfani da bincike na in vitro.
Novel coronaviruses na cikin nau'in β.COVID-19 cuta ce mai saurin kamuwa da numfashi.Mutane gabaɗaya suna da sauƙi.A halin yanzu, majinyatan da suka kamu da sabon coronavirus sune tushen kamuwa da cuta;Mutanen da suka kamu da asymptomatic suma suna iya zama tushen kamuwa da cuta.
Lepu Medical COVID-19 Antigen Saliva Test Kit AMDNA12
Dangane da binciken cututtukan cututtuka na yanzu, lokacin shiryawa shine kwanaki 1 zuwa 14, galibi daga kwanaki 3 zuwa 7.Babban bayyanar cututtuka sun haɗa da zazzabi, gajiya da bushewar tari.Ana samun cunkoso na hanci, hanci, ciwon makogwaro, myalgia da gudawa a wasu lokuta.Ana iya gano Antigen gabaɗaya a cikin samfuran numfashi na sama a lokacin babban lokacin kamuwa da cuta.
Gaggawar gano cutar ta SARS-CoV-2 zai taimaka wa ƙwararrun kiwon lafiya don kula da marasa lafiya da sarrafa cutar da kyau da inganci.
Lepu Medical COVID-19 Kit ɗin gwajin Antigen Saliva AMDNA12 ya dogara ne akan ƙa'idar takamaiman takamaiman maganin antibody-antigen da colloidal zinariya alamar fasahar bincike na immunochromatographic.Reagent ya ƙunshi COVID-19 monoclonal antibody prefixed a cikin wurin gwaji (T) akan membrane da COVID-19 monoclonal antibody wanda aka lulluɓe akan cakuda gwal-colloidal pad.
Lepu Medical COVID-19 Antigen Saliva Test Kit AMDNA12
Samfurin yana digowa cikin samfurin da kyau kuma yana amsawa tare da COVID-19 monoclonal antibody wanda ke ɗaure da barbashi na gwal ɗin da aka riga aka rufe lokacin gwaji.Sannan cakuda yana chromatographed zuwa sama tare da tasirin capillary.Idan ta tabbata, maganin rigakafin da aka yi wa lakabi da gwal ɗin colloidal zinariya zai fara ɗaure ga ƙwayar cuta ta COVID-19 a cikin samfurin yayin chromatography.Sannan an ɗaure masu haɗin gwiwa ta hanyar COVID-19 monoclonal antibody wanda aka kafa akan membrane, kuma jan layi ya bayyana a yankin gwajin (T).Idan mara kyau ne, babu jajayen layi a wurin gwajin (T).Ko samfurin ya ƙunshi antigen na COVID-19 ko a'a, jan layi zai bayyana a yankin kula da inganci (C).
Layin jan da ke bayyana a cikin yankin kula da ingancin (C) shine ma'auni don yin hukunci ko akwai isassun samfuran kuma ko tsarin chromatographic al'ada ne, kuma yana aiki azaman ma'aunin kulawa na ciki don reagent.
Lepu Medical COVID-19 Kit ɗin gwajin Antigen Saliva AMDNA12 Fasaloli:
Nau'in samfurori: Saliva
Lokacin gwaji: Minti 15
Hankali: 98.10%
Musamman:> 99.33%
Kayan aikin Lepu Medical COVID-19 Antigen Saliva Test Kit AMDNA12 tsiri a cikin kaset:
Samfurin kushin: ya ƙunshi buffered salts da detergents.
Label pad: ya ƙunshi linzamin kwamfuta mai lakabin zinare anti-COVID-19 antibody monoclonal.Nitrocellulose membrane:
Wurin sarrafawa: ya ƙunshi goat anti-mouse IgG polyclonal antibody da buffer.Wurin gwaji: ya ƙunshi linzamin kwamfuta anti-COVID-19 monoclonal antibody da buffer.Absorbent pad: An yi shi da takarda mai ɗaukar nauyi sosai.
